Key result
Serum PCSK9 levels were directly correlated with carotid-femoral pulse wave velocity, explaining 16.9% of its variation in type 2 diabetic patients without previous cardiovascular events.
Why the study?
The correlation between serum PCSK9 levels and arterial stiffness in type 2 diabetic patients without previous cardiovascular events was not well established.
Do serum PCSK9 levels correlate with arterial stiffness in Caucasian patients with type 2 diabetes without previous cardiovascular events?
Cross-Sectional (n=401)
Do serum PCSK9 levels correlate with arterial stiffness in Caucasian patients with type 2 diabetes without previous cardiovascular events?
Circulating PCSK9 levels are closely associated with arterial stiffness in T2DM subjects without previous CV events, suggesting its potential utility as a biomarker for cardiovascular risk stratification.
Answers are grounded in this paper and cite their sources.
PCSK9 levels were associated with higher PWV in T2DM without prior events; hypothesis-generating for vascular risk assessment, needs prospective validation.
BACKGROUND: Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) levels have been suggested as novel atherosclerotic biomarker. PCSK9 plays important roles in the pathogenesis of atherosclerosis by regulating the degradation of low-density lipoprotein receptor as well as different inflammatory pathways. Considering the important prognostic role of arterial stiffness in cardiovascular disease (CVD), the aim of the study is to investigate the correlation between PCSK9 levels and arterial stiffness in a cohort of diabetic patients, without previous CV events. METHODS: This cross-sectional analysis enrolled 401 Caucasian patients with type II diabetes mellitus (T2DM). PCSK9 levels were measured by ELISA test, arterial stiffness was estimated by measuring carotid-femoral pulse wave velocity (PWV). RESULTS: Patients were divided in three tertiles according to increasing value of PCSK9. From the I to the III tertiles, there was a significant increase in high sensitivity C-reactive protein (hs-CRP), fibrinogen and white blood cells (WBC) and a reduction in estimated glomerular filtration rate (e-GFR). Patients with higher levels of PCSK9 presented increased systolic, diastolic blood pressure, pulse pressure and PWV. PWV was significantly and directly correlated with PCSK9, fibrinogen, age, BMI and PP, and indirectly correlated with diet, lifestyle and e-GFR. Serum PCSK9 was the major predictor of PWV, justifying a 16.9% of its variation. CONCLUSION: Our study demonstrates a close association between circulating PCSK9 levels and PWV in T2DM subjects without previous CV events even after adjusting for well-known CV risk factor and pharmacological medications. Serum PCSK9 could be a useful biomarker for CV risk stratification in diabetic subjects.
No takes yet. Share an insight, caveat, or question.
Armentaro et al. (2022) conducted a cross-sectional in Type 2 diabetes mellitus (n=401). Serum PCSK9 levels vs. Lower PCSK9 levels was evaluated on Carotid-femoral pulse wave velocity (PWV). Serum PCSK9 levels were directly correlated with carotid-femoral pulse wave velocity, explaining 16.9% of its variation in type 2 diabetic patients without previous cardiovascular events.
Synapse has enriched 10 related papers. Consider them for comparative context: